Login
- Dokumenttyp:
- Journal Article; Research Support, Non-U.S. Gov't
- Autor(en):
- Weingold, Robert; Zinman, Bernard; Mattheus, Michaela; Ofstad, Anne Pernille; Steubl, Dominik; Wanner, Christoph; Inzucchi, Silvio E
- Titel:
- Shifts in KDIGO CKD risk groups with empagliflozin: Kidney-protection from SGLT2 inhibition across the spectrum of risk.
- Abstract:
- T2D is a well-established risk factor for development and progression of CKD. KDIGO recommends categorization of risk by likelihood of progression to ESKD. Compared to placebo, empagliflozin decreases likelihood of worsening (OR 0.70, 95 % CI 0.62-0.78) and increases likelihood of improvement (OR 1.56, 95 % CI 1.30-1.86) in KDIGO risk category.
- Zeitschriftentitel:
- J Diabetes Complications
- Jahr:
- 2023
- Band / Volume:
- 37
- Heft / Issue:
- 11
- Volltext / DOI:
- doi:10.1016/j.jdiacomp.2023.108628
- PubMed:
- http://view.ncbi.nlm.nih.gov/pubmed/37852075
- Print-ISSN:
- 1056-8727
- TUM Einrichtung:
- Professur für Nephrologie (Prof. Heemann)
BibTeX